World's Best Scientists 2026 revealed!
Asian Journal of Pharmaceutical Sciences
H-index 30

Asian Journal of Pharmaceutical Sciences

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Chemistry 447 18 32 18

Additional Metrics

Number of Best Scientists*: 77
Documents by Best Scientists*: 90
Top 100 Ranked Scientists*: 5
SCIMAGO H-index: 76
SCIMAGO SJR: 2.251
Impact Factor: 11.9

Overview

Top Research Topics at Asian Journal of Pharmaceutical Sciences?

Asian Journal of Pharmaceutical Sciences mainly tackles studies in Chromatography, Pharmacology, Drug delivery, In vivo and Pharmacokinetics. Chromatography research featured in the journal incorporates concerns from various other topics such as Solubility, Particle size, Polymer and Dissolution. Amorphous solid, Dispersion (chemistry), Differential scanning calorimetry and Nuclear chemistry are some topics wherein Dissolution research discussed in the journal have an impact.

The studies tackled, which mainly focus on Differential scanning calorimetry, apply to Fourier transform infrared spectroscopy as well. The Pharmacology study tackled is a key component of adjacent topics in the area of Liposome. The journal focuses on Drug delivery research as part of the broader topic of Nanotechnology.

The studies on In vivo discussed can also contribute to research in the domains of Biophysics and In vitro. The majority of Chemical engineering studies are focused on the issues of Nanoparticle.

  • Chromatography (24.11%)
  • Pharmacology (21.54%)
  • Drug delivery (15.41%)

What are the most cited papers published in the journal?

  • Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability (457 citations)
  • A review on phospholipids and their main applications in drug delivery systems (413 citations)
  • The endocytosis and intracellular fate of nanomedicines: Implication for rational design (329 citations)

Research areas of the most cited articles at Asian Journal of Pharmaceutical Sciences:

The journal publications are mainly concerned with subjects like Drug delivery, Pharmacology, Drug, Nanotechnology and Chromatography. The most cited articles facilitate discussions on Pharmacology that incorporate concepts from other fields like Biochemistry and In vivo. The works on Chromatography tackled in the published papers bring together disciplines like Pectin, Polymer, Chemical engineering, Pulmonary surfactant and Solubility.

What topics the last edition of the journal is best known for?

  • Enzyme
  • Internal medicine
  • Biochemistry

The previous edition focused in particular on these issues:

The objective of the journal is to combine knowledge in the areas of In vivo, Drug, Drug delivery, Cancer research and Nanocarriers. The research on In vivo tackled can also make contributions to studies in the areas of In vitro, Cytotoxicity, Biophysics, Doxorubicin and Combinatorial chemistry. The featured Drug study falls within the wider topic of Pharmacology.

Pharmacology research presented in the journal encompasses a variety of subjects, including Tacrolimus and Ulcerative colitis. Topics in Drug delivery were tackled in line with various other fields like Chitosan, Intensive care medicine, Disease, Computational biology and Nanomedicine. The work on Bioavailability tackled in Asian Journal of Pharmaceutical Sciences brings together disciplines like Chemical engineering, Dissolution, Rheumatoid arthritis and Corneal penetration.

The most cited articles from the last journal are:

  • 3D printed tacrolimus suppositories for the treatment of ulcerative colitis. (21 citations)
  • Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development. (14 citations)
  • Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities. (12 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Asian Journal of Pharmaceutical Sciences (based on the number of publications) are:

  • Zhonggui He (35 papers) published 5 papers at the last edition, 2 more than at the previous edition,
  • Jin Sun (33 papers) published 3 papers at the last edition, 2 less than at the previous edition,
  • Pornsak Sriamornsak (21 papers) absent at the last edition,
  • Keiichi Motoyama (16 papers) published 1 paper at the last edition,
  • Jong Oh Kim (15 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Asian Journal of Pharmaceutical Sciences (based on the number of publications) are:

  • Shenyang Pharmaceutical University (176 papers) published 9 papers at the last edition the same number as at the previous edition,
  • Silpakorn University (35 papers) absent at the last edition,
  • Kumamoto University (21 papers) published 1 paper at the last edition,
  • Yeungnam University (15 papers) absent at the last edition,
  • China Pharmaceutical University (14 papers) published 3 papers at the last edition, 1 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 6.45% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 31.03% were posted by at least one author from the top 10 institutions publishing in the journal. Another 22.41% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 6.90% of all publications and 39.66% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Research and development of drug delivery systems based on drug transporter and nano-formulation.

    Yi Peng;Lu Chen;Sheng Ye;Yu Kang

    (2020)
    104 Citations
  • Role of nanoparticle-mediated immunogenic cell death in cancer immunotherapy.

    Yajie Sun;Xiangru Feng;Chao Wan;Jonathan F. Lovell

    (2021)
    77 Citations
  • Trends of nanotechnology in type 2 diabetes mellitus treatment.

    Yannis V. Simos;Yannis V. Simos;Konstantinos Spyrou;Michaela Patila;Niki Karouta

    (2021)
    72 Citations
  • Use of graphene-based materials as carriers of bioactive agents.

    Wing-Fu Lai;Wing-Fu Lai;Wing-Tak Wong

    (2021)
    71 Citations
  • An overview on recent in vivo biological application of cerium oxide nanoparticles.

    Baskaran Stephen Inbaraj;Bing-Huei Chen

    (2020)
    70 Citations
  • Calcium ion nanomodulators for mitochondria-targeted multimodal cancer therapy

    (2021)
    66 Citations
  • Biointerface engineering nanoplatforms for cancer-targeted drug delivery.

    Huaiyu Zhang;Huaiyu Zhang;Shujun Dong;Zhongmin Li;Zhongmin Li;Xiangru Feng

    (2020)
    60 Citations
  • Small changes in the length of diselenide bond-containing linkages exert great influences on the antitumor activity of docetaxel homodimeric prodrug nanoassemblies.

    Lingxiao Li;Shiyi Zuo;Fudan Dong;Tian Liu

    (2021)
    48 Citations
  • Iron-doxorubicin prodrug loaded liposome nanogenerator programs multimodal ferroptosis for efficient cancer therapy

    (2021)
    40 Citations
  • Osteoimmunity-regulating biomaterials promote bone regeneration

    (2023)
    39 Citations

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to various rewarding career paths and specialized online degrees. Many students consider advancing their education through programs such as the pharmacist accelerated program, which fast-tracks the journey to becoming a licensed pharmacist.

For those interested in the business side of pharmaceuticals, understanding how to get into pharmaceutical sales is invaluable. This career blends scientific knowledge with sales strategies, offering diverse opportunities in healthcare markets.

Alternatively, careers in medical coding provide another pathway by leveraging chemistry and healthcare knowledge. Obtaining a CPC certification salary can boost credibility and earning potential in this growing field.

For those committed to healthcare and patient care, exploring how do you become a pharmacist offers detailed guidance on the educational and professional requirements to enter this vital profession.

Best Scientists Contributing to This Journal

Recently Published Articles